Prime Medicine (PRME) Total Liabilities (2021 - 2026)

Prime Medicine (PRME) has 6 years of Total Liabilities data on file, last reported at $218.0 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 1.45% year-over-year to $218.0 million; the trailing twelve-month figure through Mar 2026 stood at $218.0 million (down 1.45% YoY), and the FY2025 full-year result was $221.9 million, up 53.69% from the prior year.
• Total Liabilities for Q1 2026 stood at $218.0 million, down from $221.9 million in the prior quarter.
• Across five years, Total Liabilities topped out at $223.2 million in Q3 2025 and bottomed at $38.1 million in Q1 2023.
• The 5-year median for Total Liabilities is $143.3 million (2024), against an average of $126.7 million.
• The widest annual swing landed in 2023, when Total Liabilities plunged 79.1%; it then surged 245.63% in 2025.
• A 5-year view of Total Liabilities shows it stood at $44.0 million in 2022, then surged by 38.0% to $60.8 million in 2023, then surged by 137.51% to $144.4 million in 2024, then surged by 53.69% to $221.9 million in 2025, then decreased by 1.73% to $218.0 million in 2026.
• The last three Total Liabilities figures came in at $218.0 million (Q1 2026), $221.9 million (Q4 2025), and $223.2 million (Q3 2025), per Business Quant data.

Peer Comparison